Articles
The effects of improving sleep on mental health (OASIS):
a randomised controlled trial with mediation analysis
Daniel Freeman, Bryony Sheaves, Guy M Goodwin, Ly-Mee Yu, Alecia Nickless, Paul J Harrison, Richard Emsley, Annemarie I Luik, Russell G Foster,
Vanashree Wadekar, Christopher Hinds, Andrew Gumley, Ray Jones, Stafford Lightman, Steve Jones, Richard Bentall, Peter Kinderman,
Georgina Rowse, Traolach Brugha, Mark Blagrove, Alice M Gregory, Leanne Fleming, Elaine Walklet, Cris Glazebrook, E Bethan Davies, Chris Hollis,
Gillian Haddock, Bev John, Mark Coulson, David Fowler, Katherine Pugh, John Cape, Peter Moseley, Gary Brown, Claire Hughes, Marc Obonsawin,
Sian Coker, Edward Watkins, Matthias Schwannauer, Kenneth MacMahon, A Niroshan Siriwardena, Colin A Espie
Summary
Background Sleep difficulties might be a contributory causal factor in the occurrence of mental health problems. If Lancet Psychiatry 2017;
this is true, improving sleep should benefit psychological health. We aimed to determine whether treating insomnia 4: 749–58
leads to a reduction in paranoia and hallucinations. Published Online
September 6, 2017
http://dx.doi.org/10.1016/
Methods We did this single-blind, randomised controlled trial (OASIS) at 26 UK universities. University students with
S2215-0366(17)30328-0
insomnia were randomly assigned (1:1) with simple randomisation to receive digital cognitive behavioural therapy (CBT)
See Comment page 734
for insomnia or usual care, and the research team were masked to the treatment. Online assessments took place at
Department of Psychiatry,
weeks 0, 3, 10 (end of therapy), and 22. The primary outcome measures were for insomnia, paranoia, and hallucinatory
University of Oxford,
experiences. We did intention-to-treat analyses. The trial is registered with the ISRCTN registry, number ISRCTN61272251. Warneford Hospital, Oxford,
UK (Prof D Freeman PhD,
B Sheaves DClinPsy,
Findings Between March 5, 2015, and Feb 17, 2016, we randomly assigned 3755 participants to receive digital CBT for
Prof G M Goodwin FMedSci,
insomnia (n=1891) or usual practice (n=1864). Compared with usual practice, the sleep intervention at 10 weeks
Prof P J Harrison DM Oxon,
reduced insomnia (adjusted difference 4·78, 95% CI 4·29 to 5·26, Cohen’s d=1·11; p<0·0001), paranoia (–2·22, V Wadekar MSc , C Hinds DPhil);
–2·98 to –1·45, Cohen’s d=0·19; p<0·0001), and hallucinations (–1·58, –1·98 to –1·18, Cohen’s d=0·24; p<0·0001). Oxford Health National Health
Service (NHS) Foundation
Insomnia was a mediator of change in paranoia and hallucinations. No adverse events were reported.
Trust, Oxford, UK
(Prof D Freeman, B Sheaves,
Interpretation To our knowledge, this is the largest randomised controlled trial of a psychological intervention for a Prof G M Goodwin,
mental health problem. It provides strong evidence that insomnia is a causal factor in the occurrence of psychotic Prof P J Harrison); Nuffield
Department of Primary Care
experiences and other mental health problems. Whether the results generalise beyond a student population requires
Health Sciences, University of
testing. The treatment of disrupted sleep might require a higher priority in mental health provision. Oxford, Oxford, UK
(L-M Yu DPhil, A Nickless MSc);
Funding Wellcome Trust. Centre for Biostatistics,
Institute of Population Health,
Manchester University,
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Manchester Academic Health
Centre, Manchester, UK
Introduction substantiated further by use of mediation analysis.5,6 In (Prof R Emsley PhD); Sleep and
Circadian Neuroscience
Sleep problems are a common occurrence in patients the present study, we aimed to improve sleep in
Institute, Nuffield Department
with mental health disorders. The traditional view is that individuals with insomnia to determine the effect on of Clinical Neurosciences,
disrupted sleep is a symptom, consequence, or non- psychotic experiences. This approach therefore informs University of Oxford,
specific epiphenomenon of the disorders; the clinical both theoretical understanding and clinical practice. Sir William Dunn School of
Pathology, Oxford, UK
result is that the treatment of sleep problems is given a The most common form of sleep disruption is insomnia,
(A I Luik PhD,
low priority. An alternative perspective is that disturbed comprising sustained difficulties in initiating or staying Prof R G Foster PhD,
sleep is a contributory causal factor in the occurrence of asleep, or both, which cause problems during the day. The Prof C A Espie PhD); Big Health
many mental health disorders.1 An escalating cycle then association of insomnia with psychotic experiences in the Ltd, London, UK (A I Luik,
Prof C A Espie); Institute of
emerges between the distress of the mental health general population has been established.3 There are
Health and Wellbeing,
symptoms, effect on daytime functioning, and struggles multiple, independent, psychotic experiences. Each University of Glasgow,
in gaining restorative sleep. From this alternative psychotic experience exists on a spectrum of severity in Gartnavel Royal Hospital,
Glasgow, UK
perspective, the treatment of sleep problems attains a the general population with differing heritability and
(Prof A Gumley PhD); School of
higher clinical importance. We are particularly interested differing strength of association with insomnia.7 Paranoia
Nursing and Midwifery, Faculty
in the putative causal association between disturbed sleep and hallucinations have the strongest links with of Health and Human Sciences,
and psychotic experiences.2,3 The interventionist–causal insomnia.2,7,8 However, the effect of altering the amount of Plymouth University,
Plymouth, UK
model approach to establishment of a causal association sleep disruption—eg, by targeted sleep treatment—on
(Prof R Jones PhD);
is to manipulate the hypothesised mechanistic variable these psychotic experiences remains to be established.
Henry Wellcome Laboratories
and observe the effect on the outcome of interest;4 if Clinical guidelines recommend the use of cognitive for Integrative Neuroscience
a causal association exists then the outcome variable behavioural therapy (CBT) as the first-line treatment for and Endocrinology, University
of Bristol, Bristol, UK
should alter. The effects of the manipulation can then be insomnia.9 Digital forms of CBT for insomnia that require
www.thelancet.com/psychiatry Vol 4 October 2017 749
Articles
(Prof S Lightman PhD);
Spectrum Centre for Mental Research in context
Health Research, Faculty of
Evidence before this study first study adequately powered to determine the effects of
Health and Medicine, Lancaster
University, Lancaster, UK If insomnia is a contributory cause of psychotic experiences, then treating sleep dysfunction on psychotic experiences. It shows
(Prof S Jones PhD); the key test is whether improving sleep will lead to a reduction in very clearly that treatment of insomnia in students leads to a
Psychological Sciences,
psychotic experiences. We therefore searched for randomised reduction in psychotic experiences. A mediation analysis
Institute of Psychology Health
controlled studies that set out to reduce insomnia and examine supports this interpretation. Furthermore, the trial is
and Society, University of
Liverpool, Liverpool, UK the effects on psychotic experiences. On June 23, 2017, we consistent with a small number of other randomised
(Prof P Kinderman PhD); Clinical searched the entire archive (ie, using no date restrictions) of controlled trials that indicate multiple other benefits for
Psychology Unit, Department
PubMed for: (Sleep OR Insomnia) AND (Delus* OR Hallucinat* OR mental health when treating sleep problems.
of Psychology, University of
Sheffield, Sheffield, UK Psychosis OR Psychotic OR Schizophren*) AND (CBT OR hypnotic Implications of all the available evidence
(Prof R Bentall PhD, OR medication) AND (Random* OR RCT). 130 papers were
Sleep disruption might have a contributory causal role in the
G Rowse DClinPsy); Department identified and only two were randomised controlled trials that
of Health Sciences, College of occurrence of psychotic experiences and a wide range of other
tested the effects of sleep treatment on psychotic experiences,
Medicine, Biological Sciences mental health problems. Adequately powered tests in other
and Psychology, Centre for with the larger of the trials being our own with 50 patients with populations would be helpful, but research indicating that the
Medicine, University of schizophrenia or related disorders. These trials were
treatment of disrupted sleep requires a higher priority in
Leicester, Leicester, UK underpowered to determine with any precision the potential link
(Prof T Brugha MD); mental health provision is accumulating.
between insomnia and psychotic experiences.
Department of Psychology,
University of Swansea,
Added value of this study
Swansea, UK
We undertook what might be the largest randomised
(Prof M Blagrove PhD);
Department of Psychology, controlled trial to date of a psychological treatment. It is the
Goldsmiths, University of
London, London, UK
(Prof A M Gregory PhD);
Department of Psychology, no therapist to be present have been shown to be in this general population group. Our secondary aims
University of Strathclyde, efficacious as well.10–12 In patients with current delusions were to investigate whether digital CBT for insomnia,
Glasgow, UK (L Fleming PhD);
and hallucinations, results of our pilot randomised compared with usual practice, reduced depression, anxiety,
Department of Psychology,
Institute of Health and Society, controlled trial13 have shown that insomnia can be nightmares, and mania; improved psychological wellbeing;
University of Worcester, substantially reduced with CBT, but the trial was and led to the occurrence of fewer mental health disorders.
Worcester, UK (E Walklet MSc); underpowered to establish with sufficient precision the
Division of Psychiatry and consequences for psychotic experiences. Therefore, we Methods
Applied Psychology, School of
Medicine undertook a clinical trial that was large enough to Study design and participants
(Prof C Glazebrook PhD, definitively test the causal association between insomnia We did this single-blind, randomised controlled trial
Prof C Hollis PhD) and National and self-reported psychotic experiences. (OASIS; Oxford Access for Students Improving Sleep) of
Institute for Healthcare
To test thousands of individuals, we did an online study digital CBT versus treatment as usual (usual practice).
Research MindTech Healthcare
Technology Co-operative, using digital CBT for insomnia treatment. A participant Screening, informed consent, assessments, allocation to
Institute of Mental Health pool (university students) was selected that would be easily condition, and the delivery of the intervention were
(Prof C Glazebrook, reachable (since we would have access to large email lists) carried out online using an automated system, a specially
E B Davies PhD, Prof C Hollis),
and at an age when mental health disorders emerge. We configured instance of True Colours, which is a system
University of Nottingham,
Nottingham, UK; Division of have previously shown in a student population that sleep for the scheduled collection of outcome measures.14
Psychology and Mental Health, problems are associated with elevated levels of paranoia, Participants in the control group were given access to the
School of Health Sciences,
hallucinations, anxiety, depression, and manic symptoms.8 sleep intervention after their final assessment. The study
University of Manchester,
Our main aim required a comparison between the received overall ethical approval from the University
Manchester, UK
(Prof G Haddock PhD); School of effects of a reduction in insomnia (in a group receiving of Oxford Medical Sciences Inter-Divisional Ethics
Psychology and Therapeutic recommended treatment) and continued sleep disruption Committee and then local approvals at the other
Studies, University of South
(in a group receiving usual care, which is likely to mean participating universities. The OASIS trial protocol has
Wales, Treforest, UK
(Prof B John PhD); Department
receiving little or no treatment). Clear change in sleep in been published.15
of Psychology, School of one group relative to another was required to test the Participants were eligible if they were attending
Science and Technology, mechanistic hypothesis. We were not investigating the university; had a positive screen for insomnia, as indicated
University of Middlesex,
intervention elements that might lead to change. Our by a score of 16 or lower on the Sleep Condition Indicator
London, UK (M Coulson PhD);
Department of Psychology, primary aim was to find out whether CBT for insomnia, (SCI);16 and were 18 years or older. We had no exclusion
University of Sussex, Brighton, compared with a usual practice control group, reduced criteria. 26 UK universities took part (appendix 1),
UK (Prof D Fowler MSc); Sussex insomnia and reduced paranoia and hallucinations by the ensuring a range in geographical locations and academic
Partnership NHS Foundation
end of treatment, and whether the changes in insomnia ability. The principal method of recruitment was sending
Trust, Worthing, UK
(Prof D Fowler, K Pugh DClinPsy); mediated the changes in psychotic experiences. We also a circular email within universities that contained a link to
Department of Clinical, aimed to determine the potential effects of sleep the web-based screening. When a circular email was not
Educational and Health improvement on a wider range of mental health outcomes possible, recruitment was via advertisment on websites
750 www.thelancet.com/psychiatry Vol 4 October 2017
Articles
and displaying posters, or both. Recruitment began on introduced in the third session of the course. The Psychology, University College
March 5, 2015, and ended on Feb 17, 2016. We collected animated therapist proposes a new sleep window, which London, London, UK
the final data on July 28, 2016. is calculated from the sleep diary data, and engages with (J Cape PhD); School of
Psychology, University of
the participant to help them select the timing of the
Central Lancashire, Preston, UK
Randomisation and masking window (eg, earlier versus later in the night). A more (P Moseley PhD); Psychology
As recommended for large clinical trials,17 we used lenient sleep window is used for those individuals Department, Royal Holloway,
Egham, UK (G Brown PhD);
simple randomisation (1:1) with an automated online reporting substantial physical problems, other mental
University of Cambridge Centre
system, ensuring that the research team was unable to health problems, or moderate-to-severe sleepiness. The
for Family Research,
affect randomisation. Participants completed all the sleep window is regularly reviewed at each session after it Cambridge, UK
assessments independently online and therefore their has been introduced. If the sleep diary data indicate a (Prof C Hughes PhD); School of
Psychological Sciences and
responses could not be affected by the trial team. sleep efficiency of 90% or higher, the animated therapist
Health, University of
advises that 15 min is added to the sleep window.
Strathclyde, Glasgow UK
Procedures Throughout the course of therapy, participants had access (M Obonsawin PhD);
Assessments took place at weeks 0 (baseline), 3, 10 (end of to a moderated online community and an online library Department of Clinical
Psychology, Norwich Medical
therapy), and 22. The week 3 assessment comprised only of information about sleep. Participants could also view
School, University of
the primary outcome measures. The week 3 assessment their online case file, which included four sections: a East Anglia, Norwich, UK
was carried out to assess in the mediation analyses the progress review, a reminder of strategies, an agreed sleep (Prof S Coker DPhil); SMART
temporal order of changes. Participants received an email schedule, and a list of further reading. Usual practice Lab, College of Life and
Environmental Sciences,
prompt to complete the assessments online. The order of (treatment as usual) referred to the current care that the
Sir Henry Wellcome Building
the assessments was consistent across timepoints. If participants were receiving. The amount of treatment for Mood Disorders Research,
participants did not complete the assessment, then they input was likely to be minimal, with prescription of University of Exeter, Exeter, UK
received up to two email reminders 2 days apart. medication for a small proportion. We did not attempt to (Prof E Watkins PhD); School of
Health in Social Sciences,
The CBT for insomnia intervention is called Sleepio.11,18 alter the current care that participants received.
University of Edinburgh,
It is provided in six sessions, lasting an average of 20 min Medical School, Edinburgh, UK
each. Sessions are unlocked weekly, although participants Outcomes (Prof M Schwannauer PhD,
can move at a slower pace. The full programme is The primary outcomes were insomnia, paranoia, and K MacMahon PhD); and
Community and Health
accessible via any web browser and all participants start hallucinatory experiences. The primary measure for
Research Unit, University of
the programme online. Certain tools (eg, sleep diaries insomnia was the SCI-8.16 This score is an 8-item Lincoln, Lincoln, UK
and relaxation audios) could also be accessed using the measure, validated against DSM-5 criteria, assessing (Prof A N Siriwardena PhD)
web browser of a smartphone. All of the sessions, sleep sleep and its impact on daytime functioning over the past Correspondence to:
diaries, relaxation audios, and the scheduling tool could week. Scores can range from 0 to 32 with higher scores Prof Daniel Freeman, Department
of Psychiatry, University of
be accessed with an iPhone. Completion of an initial indicating better sleep. A clinical cutoff of less than
Oxford, Warneford Hospital,
assessment drives the algorithms that personalise the 17 correctly identifies 89% of individuals with probable Oxford OX3 7JX, UK
programme. For example, the assessment leads to a insomnia disorder. We used a version of the SCI that daniel.freeman@psych.ox.ac.uk
tailored choice of treatment goal, with progress then included one additional question, as a secondary outcome, See Online for appendix 1
reviewed at each subsequent session. The treatment regarding early morning waking. The internal consistency For more on Sleepio see
includes behavioural, cognitive, and educational com- (Cronbach’s α at baseline) of the scale in the present study www.sleepio.com
ponents. The behavioural techniques include sleep was 0·63.
restriction (ie, reducing the sleep window to enhance Paranoia was assessed with the Green et al Paranoid
sleep consolidation), stimulus control (eg, getting out of Thought Scales (GPTS), part B.19 This scale assesses
bed after 15–20 min of wakefulness), and relaxation persecutory ideation, and the timeframe used was the
(eg, tensing and relaxing muscles when in bed). The past fortnight. The scale comprises 16 items, each rated
cognitive techniques include paradoxical intention on a 1 (not at all) to 5 (totally) scale. High scores indicate
(eg, trying to stay awake), belief restructuring (eg, targeting higher levels of paranoia. The internal consistency of the
unrealistic expectations about sleep), mindfulness scale in the present study was 0·94.
(eg, acknowledging thoughts and feelings without The measure for hallucinations was the Specific
dwelling on them), imagery (eg, generating positive Psychotic Experiences Questionnaire—Hallucinations
mental images), and putting the day to rest (eg, setting subscale.20 The scale comprises nine items rated on a
time aside to reflect on the day). The educational 0 (not at all) to 5 (more than once per day) scale. The
component covers information about the processes of timeframe was the past fortnight. Higher scores indicate
sleep and sleep hygiene. The programme is interactive, greater occurrences of hallucinatory experiences. The
and content is presented by an animated therapist. internal consistency of the scale in the present study
Participants make a time for the session and are prompted was 0·93.
via email or text message via a short message service if The secondary outcome measures for sleep were the
they do not attend. Participants complete daily sleep Insomnia Severity Index (ISI;21 Cronbach’s α in the
diaries throughout the intervention, which are used by present study=0·67) and the Disturbing Dreams and
the programme to tailor the advice. Sleep restriction is Nightmare Severity Index22 (Cronbach’s α in the present
www.thelancet.com/psychiatry Vol 4 October 2017 751
Articles
study=0·91). The secondary outcome measure for collected at repeated timepoints,30 and in this trial
psychotic experiences was the 16-item version of the included outcome data at weeks 3, 10, and 22 available
Prodromal Questionnaire23 (Cronbach’s α in the present for all participants who had been randomly assigned.
study=0·79). A score of 6 or more has 87% specificity and The method has the advantage of implicitly accounting
87% sensitivity to correctly classify ultra-high risk for for data missing at random. The estimated (adjusted)
psychosis mental states in a help-seeking sample. treatment differences from these analyses are therefore
The measures to assess affective symptoms were the reported. The linear mixed effects models included the
Patient Health Questionnaire 9-item version24 (PHQ-9; outcome as the response variable, timepoint, randomised
Cronbach’s α in the present study=0·85), the Generalised group, and baseline score as fixed effects and random
Anxiety Disorder 7-item version25 (GAD-7; Cronbach’s α effects were estimated for students nested within
in the present study=0·89), and the Altman Mania Scale26 universities. A student is located within one university,
(Cronbach’s α in the present study=0·64). Psychological and so to estimate the random intercepts, we accounted
wellbeing was assessed with the Warwick–Edinburgh for random variation between universities and between
Mental Wellbeing Scale (WEMWBS;27 Cronbach’s α in students within the same university. We modelled an
the present study=0·89), and the Work and Social interaction between time and randomised group as a
Adjustment Scale (WSAS;28 Cronbach’s α in the present fixed effect to allow estimation of treatment effect at all
study=0·83). three timepoints. Sex and course level were included as
To assess the development of mental health disorders, covariates in the model. We used an unstructured
we used established cutoffs on the Prodromal variance–covariance matrix to model the within-subject
Questionnaire,23 Altman Mania Scale,26 PHQ,24 and error correlation structure. Results are presented as
GAD-7.25 Participants were also asked at each assessment mean adjusted differences in scores between the
timepoint whether they were in contact with mental randomised groups, with 95% CIs and associated two-
health services, had received a mental health diagnosis, sided p values. We confirmed the normality assumption
took medication for a mental health problem, or were of the residuals for each outcome. No deviations from
currently receiving any other psychological therapy. normality were apparent and therefore maximum
If the trial team were informed of the occurrence of a likelihood estimates were reported. We did sensitivity
serious adverse event for a trial participant, then this was analyses (pattern mixture models, inclusion of baseline
recorded. Serious adverse events were defined as deaths, covariates predictive of missing data, and imputation) for
suicide attempts, serious violent incidents, admissions to the three main outcomes, examining the robustness of
secure units, and formal complaints about the online the results to different assumptions regarding missing
intervention. data. We calculated standardised effect sizes with
Cohen’s d, dividing the treatment effect by the shared SD
Statistical analysis at baseline. We used similar logistic mixed effects models
We calculated the sample size on the basis of change in for the secondary binary outcomes.
paranoia (one of the two psychotic symptoms studied), To test the mediation hypotheses, we determined the
since following this intervention change would be extent of mediation of the week 3 and week 10 insomnia
expected to be lower in psychotic experiences than in scores on the week 10 paranoia and hallucination
insomnia. Based on the SDs observed from a previous outcomes. The approach used was similar to the method
study29 for the GPTS (SD 10·4), a total sample size of 2614 of Baron and Kenny,5,31 but made use of linear mixed
participants (ie, 1307 per group) would provide 90% power effects models at each step. The approach involved four
to detect a small effect size in paranoia, with a steps and three separate model fits. In two separate linear
standardised mean difference of 0·15, while accounting mixed effects models, the intervention was shown to be
for a high amount of expected attrition (40%). In a study correlated with the outcome and then with the mediator.
amendment, the sample size was increased because of a We then fitted the data to a third model with the outcome
higher than initially expected dropout rate. as the response and both the intervention and mediator
An outline of the analysis strategy was provided in the as covariates. The parameters were extracted as per Baron
published trial protocol15 and a full statistical analysis and Kenny31 to obtain the total, direct, and indirect effects,
See Online for appendix 2 plan was agreed before the trial analysis (appendix 2). All and finally the percentage mediation was determined. In
the analyses were validated by a second statistician. all models, we included baseline amounts of both the
Analyses were by intention to treat and were carried out outcome and mediator as covariates. This method is
at the end of the last follow-up assessment (with no similar to the mediation analysis in the study by Freeman
interim analyses). We analysed each continuous outcome and colleagues,32 but made use of linear mixed effects
with a linear mixed effects regression model to account models to account for repeated measurements, rather
for the repeated measures over time, and we analysed than through structural equation modelling. We used
For the protocol see binary outcomes with a logistic mixed effects model. STATA version 14.1 for the statistical analysis.
https://trialsjournal.
Mixed effects models are the recommended statistical The trial is registered with the ISRCTN registry,
biomedcentral.com/articles/
10.1186/s13063-015-0756-4 technique for analysing clinical trials when outcomes are number ISRCTN61272251.
752 www.thelancet.com/psychiatry Vol 4 October 2017
Articles
Role of the funding source (appendix 1). Treatment differences also remained
The funder of the study had no role in study design, data consistent with the primary analysis when we repeated
collection, data analysis, data interpretation, or writing of the main analyses covarying for baseline variables that
the report. The corresponding author had full access to predicted missingness for each outcome. We also used
all the data in the study and had final responsibility for pattern mixture models. Treatment differences would
the decision to submit for publication. still be significant assuming the missing individuals in
the treatment group had outcome scores 2 points worse
Results for insomnia and paranoia, and 1 point worse for
Between March 5, 2015, and Feb 17, 2016, we randomly hallucinations (predictably the hallucination scale scores
assigned 3755 participants to receive digital CBT for were much lower than for the other two outcome
insomnia (n=1891) or usual practice (n=1864; figure). variables; appendix 1).
The sample was predominately female, studying for For the mediation analyses, change in sleep over
their first university degree, and two-thirds were of 3 weeks explained 30% of the intervention effect on
white British ethnicity (table 1). Around a fifth of the paranoia at 10 weeks, with change in sleep over 10 weeks
participants were in contact with mental health services accounting for 58% of the treatment effect on paranoia
(table 1). The two randomised groups were well matched (table 3). Change in sleep over 3 weeks explained 21% of
at baseline (table 1). the intervention effect on hallucinations at 10 weeks,
Appendix 1 has the full details of the sample, missing with change in sleep over 10 weeks accounting for 39% of
data patterns, sensitivity analyses, and all other analyses. the intervention effect on hallucinations. Hence early
The dropout from the study assessments was high (50%) changes in sleep explain approximately half of the total
during the course of the study, and was greater in the sleep-mediated changes in psychotic experiences by the
treatment group than in the control group, with this figure end of treatment. In comparison, parallel analyses in the
and pattern almost identical to the most comparable opposite direction indicated that changes in psychotic
previous study.12 The baseline scores for the three primary
outcomes (insomnia, paranoia, and hallucinations) were
8448 screened for eligibility
not associated with later missingness (appendix 1).
Compared with participants who remained in the study,
participants who dropped out from both groups were 2553 excluded*
younger in age and more likely to be male (appendix 1). 2413 with SCI score above cutoff
47 younger than 18 years old
For the secondary measures, ISI, PHQ-9, Altman Mania 298 did not want help
Scale, and WSAS scores were slightly higher, and the 2140 declined to participate
WEMWBS score was slightly lower, in the missing groups
than the non-missing groups (appendix 1).
3755 randomly assigned
Treatment uptake was relatively low. In the intervention
group, 1302 participants (69%) logged on for at least one
treatment session, 953 (50%) accessed at least two sessions,
672 (36%) accessed at least three sessions, 497 (26%) 1891 allocated to intervention† 1864 allocated to usual practice
accessed at least four sessions, 390 (21%) accessed at least 1302 accessed at least one treatment
session
five sessions, and 331 (18%) accessed six sessions (figure). 672 accessed at least half the
Regarding the primary measures, the sleep treatment treatment course
331 accessed the full course
was associated with significant reductions, at all
589 did not receive allocated
timepoints, in insomnia, paranoia, and hallucinations intervention
compared with the control group (all p<0·0001; table 2).
The reduction in insomnia after treatment was large,
1158 lost to main 772 lost to main
while the reduction in psychotic experiences was small
follow-up follow-up
(table 2). After treatment, 454 (62%) of 733 individuals in assessment assessment
the treatment group and 326 (29%) of 1142 individuals in
the control group scored outside the clinical cutoff for
Primary outcomes measured in: Primary outcomes measured in:
insomnia used for trial entry. The treatment differences 1044 at week 3 1390 at week 3
were robust to the three different types of sensitivity 733 at week 10 1142 at week 10
603 at week 22 971 at week 22
analyses for missing data (appendix 1). A conservative
imputation (given the general improvement in scores in
both groups) of missing data was used, whereby the last 1152 included in intention-to-treat analysis‡ 1486 included in intention-to-treat analysis‡
available measurement for a participant was imputed for
all further missing measurements of that participant. All
Figure: Trial profile
three primary outcome differences remained significant
SCI=Sleep Condition Indicator. *Some participants excluded for two or more reasons. †Not all participants accessed
with last observation carried forward imputations all treatment sessions. ‡Had at least one measurement at week 3, 10, or 22.
www.thelancet.com/psychiatry Vol 4 October 2017 753
Articles
Control group Treatment group Control group Treatment group
(n=1864) (n=1891) (n=1864) (n=1891)
Mean age (years) 24·6 (7·6) 24·8 (7·7) (Continued from previous column)
Mean total UCAS points 753·0 (517·3) 720·8 (456·3) Mean mania (Altman) score 3·5 (3·0) 3·5 (3·0)
Sex Mean functioning (WSAS) score 17·7 (7·6) 17·6 (7·6)
Male 530 (28%) 513 (27%) Mean wellbeing (WEMWBS) score 37·9 (8·8) 37·8 (8·5)
Female 1315 (71%) 1361 (72%) Ultra-high risk of psychosis (PQ-16) cutoff (≥6)
Other 19 (1%) 17 (1%) Above 706 (38%) 711 (38%)
Course level Below 1158 (62%) 1180 (62%)
Undergraduate 1352 (73%) 1389 (73%) Depressive disorder (PHQ-9) cutoff (≥10)
Postgraduate 480 (26%) 473 (25%) Above 1238 (66%) 1286 (68%)
Other 32 (2%) 29 (2%) Below 626 (34%) 605 (32%)
Ethnic origin Anxiety disorder (GAD-7) cutoff (≥10)
White Above 781 (42%) 880 (47%)
British 1212 (65%) 1265 (67%) Below 1083 (58%) 1011 (53%)
Irish 32 (2%) 27 (1%) Mania disorder (Altman) score cutoff (≥6)
Other 284 (15%) 261 (14%) Above 422 (23%) 413 (22%)
Mixed Below 1442 (77%) 1478 (78%)
White and Caribbean 13 (1%) 11 (1%) Contact with mental health services
White and African 9 (<1%) 13 (1%) Yes 328 (18%) 346 (18%)
White and Asian 31 (2%) 27 (1%) No 1536 (82%) 1545 (82%)
Other 36 (2%) 29 (2%) Any psychiatric diagnosis
Asian Yes 590 (32%) 641 (34%)
Indian 26 (1%) 43 (2%) No 1274 (68%) 1250 (66%)
Pakistani 23 (1%) 22 (1%) Previous diagnosis of a sleep disorder
Bangladeshi 9 (<1%) 7 (<1%) Yes 93 (5%) 96 (5%)
Chinese 95 (5%) 73 (4%) No 1771 (95%) 1795 (95%)
Other 25 (1%) 32 (2%) Any psychiatric medication
Black Yes 433 (23%) 460 (24%)
African 26 (1%) 23 (1%) No 1431 (77%) 1431 (76%)
Caribbean 10 (1%) 17 (1%) Specific medication for a sleep disorder
Other 2 (<1%) 3 (<1%) Yes 51 (3%) 55 (3%)
Arab 12 (1%) 14 (1%) No 1813 (97%) 1836 (97%)
Other 19 (1%) 24 (1%) Psychological therapy
Mean insomnia (SCI-8) score 10·1 (4·3) 9·9 (4·3) Yes 146 (8%) 135 (7%)
Mean paranoia (GPTS) score 24·8 (11·6) 25·4 (11·9) No 1718 (92%) 1756 (93%)
Mean hallucinations (SPEQ) score 5·3 (6·9) 5·3 (6·4)
Data are mean (SD) or n (%). UCAS=Universities and Colleges Admissions Service.
Mean insomnia (SCI-9) score 12·1 (4·9) 11·9 (4·8) SCI-8=Sleep Condition Indicator 8-item version. GPTS=Green et al Paranoid
Thought Scales. SPEQ=Specific Psychotic Experiences Questionnaire.
Mean insomnia (ISI) score 15·3 (4·0) 15·4 (3·9)
SCI-9=SCI 9-item version. ISI=Insomnia Severity Index. DDNSI=Disturbing Dream
Mean nightmares (DDNSI) score 8·1 (8·2) 7·7 (7·8) and Nightmare Severity Index. PQ-16=Prodromal Questionnaire 16-item version.
Mean prodromal psychosis 4·9 (3·4) 4·8 (3·3) PHQ-9=Patient Health Questionnaire 9-item version. GAD-7=Generalised Anxiety
(PQ-16) score Disorder 7-item version. WSAS=Work and Social Adjustment Scale.
WEMWBS=Warwick–Edinburgh Mental Wellbeing Scale.
Mean depression (PHQ-9) score 12·7 (5·9) 12·9 (5·8)
Mean anxiety (GAD-7) score 9·0 (5·6) 9·4 (5·6) Table 1: Baseline characteristics
(Table 1 continues in next column)
just 3·8% of change in sleep and hallucinations mediated
3·4% of change in sleep. These outcomes lend further
experiences explained a much smaller percentage of support to the causal pathway hypothesis proposed in
variation in improvements in sleep. Specifically, when this study.
paranoia and hallucination outcomes at 3 weeks were set The large improvement in insomnia is confirmed with
as the mediators and the sleep outcome at 10 weeks the ISI assessment (table 4). The sleep treatment also led
as the main outcome, paranoia symptoms mediated to improvements in depression, and improvements in
754 www.thelancet.com/psychiatry Vol 4 October 2017
Articles
Insomnia (SCI-8) Paranoia (GPTS) Hallucinations (SPEQ)
Unadjusted mean Adjusted difference* p value* Unadjusted mean Adjusted difference* p value* Unadjusted mean Adjusted difference* p value*
(95% CI), d† (95% CI), d† (95% CI), d†
Control Treatment Control Treatment Control Treatment
Week 3 12·34 14·96 2·62 (2·19 to 3·06), <0·0001 24·63 22·61 –1·81 (–2·49 to –1·13), <0·0001 5·06 4·06 –0·79 (–1·15 to –0·42), <0·0001
(5·85) (5·80) 0·61 (11·82) (9·89) 0·15 (6·89) (5·84) 0·12
Week 10 13·31 18·08 4·78 (4·29 to 5·26), <0·0001 23·84 21·06 –2·22 (–2·98 to –1·45), <0·0001 4·89 3·12 –1·58 (–1·98 to –1·18), <0·0001
(6·45) (6·66) 1·11 (12·16) (9·08) 0·19 (7·24) (5·12) 0·24
Week 22 14·43 19·27 4·81 (4·29 to 5·33), <0·0001 23·84 20·75 –2·78 (–3·60 to –1·96), <0·0001 4·71 2·87 –1·56 (–1·99 to –1·14), <0·0001
(6·71) (7·13) 1·12 (12·68) (9·19) 0·24 (7·43) (5·45) 0·23
Data are mean (SD). At week 3, 1398 participants were in the control group and 1044 participants were in the treatment group. At week 10, 1142 participants were in the control group and 733 participants were in
the treatment group. At week 22, 971 participants were in the control group and 603 participants were in the treatment group. SCI-8=Sleep Condition Indicator 8-item version. GPTS=Green et al Paranoid Thought
Scales. SPEQ=Specific Psychotic Experiences Questionnaire. *Linear mixed effects model adjusted for gender, student status, week, and interaction of week with randomisation, and including a random effect for
student within university. Covariance matrix of within subject measurements was unstructured. †d is standardised effect size (Cohen’s d).
Table 2: Primary outcome results
Total effect Direct effect Indirect effect Percentage
mediated
Effect size (95% CI) p value Effect size (95% CI) p value Effect size (95% CI) p value
Paranoia (GPTS) outcome at week 10
Insomnia at week 3 (SCI-8) –2·27 (–3·03 to –1·51) <0·0001 –1·85 (–2·66 to 1·04) <0·0001 –0·67 (–0·86 to –0·48) <0·0001 29·5%
Insomnia at week 10 (SCI-8) –2·27 (–3·03 to –1·51) <0·0001 –0·97 (–1·80 to –0·14) <0·0001 –1·31 (–1·60 to –1·02) <0·0001 57·8%
Hallucinations (SPEQ) outcome at week 10
Insomnia at week 3 (SCI-8) –1·60 (–2·00 to –1·20) <0·0001 –1·36 (–1·79 to –0·94) <0·0001 –0·33 (–0·43 to –0·23) <0·0001 20·7%
Insomnia at week 10 (SCI-8) –1·60 (–2·00 to –1·20) <0·0001 –0·90 (–1·34 to –0·46) <0·0001 –0·62 (–0·78 to –0·46) <0·0001 38·6%
Total n=1718. GPTS=Green et al Paranoid Thought Scales. SCI-8=Sleep Condition Indicator 8-item version. SPEQ=Specific Psychotic Experiences Questionnaire.
*Outcome and mediators modelled by means of linear mixed effects models and the total, direct, and indirect effects determined using the Baron and Kenny31 approach.
The effect size is the adjusted treatment difference (ie, non-standardised treatment difference).
Table 3: Mediation analysis* results
anxiety, prodromal symptoms, nightmares, psychological controlled trial of a psychological intervention for a
wellbeing, and functioning, and all these improvements mental health problem. Students randomly assigned to
were maintained over time (tables 4, 5). Those participants the sleep intervention showed small, sustained reductions
randomised to the sleep treatment were also less likely to in paranoia and hallucinations, suggesting that disrupted
meet criteria over the course of the trial for a depressive sleep has a contributory causal role in the occurrence of
episode, anxiety disorder, or ultra-high risk of psychosis these psychotic experiences in a specific population of
(table 5). However, contact with mental health services young adults. The mediation analyses supported this
did not differ between groups (table 5). Furthermore, the interpretation—eg, improvements in sleep accounted for
sleep treatment led to a small, sustained increase in almost 60% of the change in paranoia after treatment.
symptoms of mania (table 5). With the sleep treatment, a Insomnia might not be the largest cause of psychotic
greater risk also existed of meeting criteria for a manic experiences but it is not an epiphenomenon. Hence, this
episode (table 5). No adverse events were reported to study adds to our understanding of the causes of psychotic
the trial team. experiences and might indicate a promising route into
the early treatment of some psychotic problems.
Discussion The focus on a sleep intervention in a young adult
We aimed to investigate the effects on mental health of population is important. Young people with incipient
the reduction of sleep difficulties. The first necessary disorders might be very reluctant to seek help for
stage was for the intervention to reduce insomnia, which psychiatric problems. Trouble sleeping is a common
was achieved. A large effect size reduction was found complaint with little stigma. Hence, it provides a much
with the digital CBT intervention in a large student more acceptable focus for a first step in a care pathway.
population. But we designed the trial to establish the The digital sleep treatment gave added benefits.
consequent effects on psychotic experiences. To our Depression in particular, but also anxiety, psychological
knowledge, the OASIS trial is the largest randomised wellbeing, nightmares, and perceived functioning all
www.thelancet.com/psychiatry Vol 4 October 2017 755
Articles
Unadjusted mean Adjusted difference* p value Adjusted odds ratio* p value
(95% CI), d† (95% CI)
Control‡ Treatment§ Ultra-high risk of psychosis (PQ-16)
Insomnia (ISI) Week 10 0·26 (0·15 to 0·46) <0·0001
Week 10 12·95 (5·27) 9·23 (5·18) –3·72 (–4·16 to –3·29), 0·94 <0·0001 Week 22 0·33 (0·18 to 0·59) 0·00026
Week 22‡ 12·17 (5·29) 8·62 (5·48) –3·40 (–3·87 to –2·93), 0·86 <0·0001 Mania (Altman)
Nightmares (DDNSI) Week 10 2·01 (1·48 to 2·73) <0·0001
Week 10 7·35 (7·85) 5·47 (6·91) –1·63 (–2·16 to –1·10), 0·20 <0·0001 Week 22 1·89 (1·34 to 2·66) 0·00027
Week 22‡§ 7·32 (7·93) 5·09 (6·66) –1·84 (–2·41 to –1·26), 0·23 <0·0001 Depressive disorder (PHQ-9)
Prodromal psychosis (PQ-16) Week 10 0·21 (0·14 to 0·32) <0·0001
Week 10 4·35 (3·71) 3·37 (3·29) –0·81 (–1·03 to –0·60), 0·24 <0·0001 Week 22 0·32 (0·21 to 0·48) <0·0001
Week 22 4·05 (3·83) 3·14 (3·24) –0·74 (–0·98 to –0·51), 0·22 <0·0001 Anxiety disorder (GAD-7)
Depression (PHQ-9) Week 10 0·32 (0·21 to 0·48) <0·0001
Week 10 11·27 (6·72) 8·44 (6·16) –2·83 (–3·30 to –2·35), 0·48 <0·0001 Week 22 0·42 (0·27 to 0·64) <0·0001
Week 22 10·34 (6·79) 8·00 (6·54) –2·44 (–2·95 to –1·94), 0·42 <0·0001 Contacted mental health services
Anxiety (GAD-7) Week 10 1·19 (0·70 to 2·04) 0·52
Week 10 8·35 (6·06) 6·53 (5·40) –1·86 (–2·29 to –1·43), 0·33 <0·0001 Week 22 0·98 (0·55 to 1·75) 0·94
Week 22 7·67 (6·10) 6·14 (5·41) –1·56 (–2·01 to –1·10), 0·28 <0·0001 Mental health diagnosis
Mania (Altman) Week 10 1·33 (0·75 to 2·37) 0·33
Week 10 2·97 (3·03) 3·77 (3·33) 0·93 (0·67 to 1·19), –0·31 <0·0001 Week 22 1·43 (0·78 to 2·63) 0·25
Week 22 2·92 (3·06) 3·57 (3·41) 0·75 (0·46 to 1·03), –0·25 <0·0001 Psychiatric medication
Functioning (WSAS) Week 10 0·77 (0·47 to 1·26) 0·30
Week 10 15·92 (8·89) 11·43 (8·37) –4·36 (–5·03 to –3·69), 0·58 <0·0001 Week 22 0·96 (0·58 to 1·59) 0·86
Week 22 14·92 (9·17) 10·25 (8·30) –4·33 (–5·05 to –3·62), 0·57 <0·0001 Psychological therapy
Wellbeing (WEMWBS) Week 10 1·27 (0·48 to 3·35) 0·63
Week 10 38·73 (9·78) 40·92 (9·63) 2·47 (1·72 to 3·22), 0·29 <0·0001 Week 22 0·41 (0·11 to 1·58) 0·20
Week 22 39·63 (10·19) 42·12 (10·36) 2·78 (1·97 to 3·60), 0·32 <0·0001
1142 participants in the control group at week 10 and 971 participants at
week 22. 733 participants in the treatment group at week 10 and 603 participants
Data are mean (SD). ISI=Insomnia Severity Index. DDNSI=Disturbing Dream and Nightmare Severity Index.
at week 22. PQ-16=Prodromal Questionnaire 16-item version. PHQ-9=Patient
PQ-16=Prodromal Questionnaire 16-item version. PHQ-9=Patient Health Questionnaire 9-item version.
Health Questionnaire 9-item version. GAD-7=Generalised Anxiety Disorder
GAD-7=Generalised Anxiety Disorder 7-item version. WSAS=Work and Social Adjustment Scale.
7-item version. *Logistic mixed effects model adjusted for gender, student status,
WEMWBS=Warwick–Edinburgh Mental Wellbeing Scale. *Linear mixed effects model adjusted for gender, student
week, and interaction of week with randomisation, and including a random effect
status, week, and interaction of week with randomisation, and including a random effect for student within university.
for student within university. Covariance matrix of within subject measurements
Covariance matrix of within subject measurements was unstructured. †d is standardised effect size (Cohen’s d).
was unstructured.
‡1142 participants in the control group at week 10 and 971 participants at week 22, except for 970 participants for
insomnia (ISI) and 963 participants for nightmares (DDNSI) at week 22. §733 participants in the treatment group at Table 5: Secondary dichotomous outcome results
week 10 and 603 participants at week 22, except for 599 participants for nightmares (DDNSI) at week 22.
Table 4: Secondary outcome results
might be needed to truly test such effects. Furthermore,
manic symptoms associated with the sleep treatment
improved. The effects on anxiety and depression are increased. This outcome might be due to an actual
consistent with the results of a meta-analysis.33 increase in problematic manic symptoms or it might
Participants who received the sleep treatment in the trial simply reflect the overall increase in psychological
were less likely to report symptoms at a level that met wellbeing in the sample since the questionnaire domains
criteria for ultra-high risk of psychosis, depression, or concern cheerfulness, self-confidence, reduced need for
anxiety disorder. At baseline, the frequency of positive sleep, increase in amount of activity, and talkativeness.
screens for psychosis risk with the Prodromal The Altman scale has been found to correlate poorly with
Questionnaire was high, similar to the risk found with self-ratings of elation.35
this questionnaire for adolescents referred to treatment Are the study results generalisable beyond a student
services;34 this high rate will reflect the well established population? We consider that the results are likely to
associations of sleep difficulties with psychotic apply to the wider adult population. We used a treatment
experiences2,3,7,8 (ie, that participants have been selected developed for adults, which was not modified for
for insomnia and therefore will score higher on psychosis students. The large treatment reduction in insomnia for
measures), and also the limitations of brief self-report the students is very similar to that found in trials with
questionnaires for assessing psychosis risk. However, in general adult populations,10,11,36 while previous studies36,37
the trial, sleep treatment did not affect contact with with community samples have shown self-help sleep
mental health services. Most participants were not in treatment to reduce anxiety and depression. Nonetheless,
contact with these services so a longer follow-up period only a direct comparison in a trial can definitively
756 www.thelancet.com/psychiatry Vol 4 October 2017
Articles
determine the generalisablilty of our findings. Although patients attending clinical services with ultra-high risk of
not the primary objective of the study, the trial does psychosis, or established clinical psychotic experiences,
indicate that the provision of internet-delivered CBT for or at the early stages of relapse. Our experience is that
insomnia to university students is likely to lead to patients with psychosis value their sleep difficulties
reductions overall in insomnia, and smaller reductions in being appropriately addressed, that this enhances
a number of other mental health symptoms, with benefits engagement with other treatments, and that better sleep
for positive psychological wellbeing too. Tailoring of the can contribute to a reduction in psychotic experiences.
intervention specifically for this population could enhance Furthermore, a gap exists in mental health services
engagement and outcome effects. Support to complete regarding intervention for early, relatively non-specific
the intervention might well be helpful too. presentations, and proper sleep treatment might provide
Several limitations exist in the study. First, the study a sensible first response. Overall, this trial indicates the
relied on self-report questionnaires, albeit validated in importance of sleep difficulties for mental health in the
their development against clinical interviews. Similar general population and the need for a reconsideration in
change captured in rater-assessed measures would have clinical services of the priority given to improving sleep.
strengthened confidence in the study results. Second,
Contributors
the samples tested were predominately in the non- DFr was the chief investigator, conceived the study, led the design,
clinical range of psychotic experiences, restricting the and drafted the paper. BS was the trial coordinator and contributed to
the design. GMG conceived the study and contributed to the design.
conclusions to the less severe end of the psychosis
L-MY contributed to the design and was responsible for the main
spectrum. Third, the participants were self-selecting in
statistical outcome analyses. AN carried out the trial analyses.
responding to the invitation, which will have affected the PJH conceived the study and contributed to the design. RE oversaw the
representativeness of the sample. However, access to the statistical mediation analysis. AIL was responsible for the digital therapy
programme. VW was responsible for the computer programming that
study was via an Internet webpage, which is a simpler
carried out the screening, assessments, and links to the digital
process than obtaining treatment from clinical services.
intervention. RGF contributed to the design of the trial. CHi was
The whole study could be completed in the privacy of the responsible for the development and coordination of the underlying
home, which means that far fewer barriers existed to True Colours platform. CAE conceived the study, contributed to the
design, and was responsible for the digital therapy programme. Other
participation than conventional patient trials. Fourth, the
authors led the research at their university site. All authors commented
extent to which the results will generalise to the rest of upon and approved the final manuscript.
the population is not known. Even within the student
Declaration of interests
population, we do not know the representativeness of the DFr reports grants from Wellcome Trust, non-financial support
participants. Fifth, bias in the outcome results will have (provision of the sleep treatment for the OASIS trial) from Sleepio, and
been introduced because of the high dropout rate, grants from the UK National Institute of Health Research (NIHR),
during the conduct of the study, and personal fees from Oxford Virtual
especially in the treatment group, which is similar to
Reality, a University of Oxford spin-out company, outside the submitted
comparable online studies.12 The results did remain work. BS reports grants from Wellcome Trust, during the conduct of the
robust against conservative assumptions in the sensitivity study, and personal fees from Big Health Ltd, outside the submitted
analyses about those participants who dropped out, but it work. GMG reports personal fees from Servier, Lundbeck and Otsuka,
Takeda, Merck, Medscape, Pfizer, P1vital, Compass Pathways, Shire,
is notable that treatment effects were greater for those
Angelini Spa, and Allergan, outside the submitted work. PJH reports
participants who completed the sleep treatment. Finally, grants from the Wellcome Trust and Medical Research Council, during
the causal argument rests on the plausible assumption the conduct of the study. The position of AIL at the University of Oxford
that the sleep treatment first changes the occurrence of is funded by Big Health Ltd. AIL reports non-financial support and other
from Big Health Ltd, during the conduct of the study, and personal fees,
insomnia, since that was the topic of the intervention,
non-financial support, and other from Big Health Ltd, outside the
but the mediation analyses in this trial based on week 10 submitted work. CHi reports grants from Roche and Eli Lilly, outside the
outcomes cannot fully capture the temporal order of submitted work. AG reports grants from NIHR HTA Grant Number
changes or rule out reverse causation. We were able to 13/15/04, outside the submitted work. PK reports research grant funding
from NIHR and the Economic and Social Research Council. SJ reports
show a significant amount of mediation based on the
research grant funding from NIHR outside the submitted work. PK is
week 3 insomnia score as a mediator, while evidence for Vice President of the British Psychological Society. AMG reports grants
reverse causation was weak, which does follow the from NIHR Maudsley Biomedical Research Centre, outside the
submitted work, and is writing a book on sleep to be published by
predicted temporal causal pathway. In reality, it is difficult
Bloomsbury Sigma. AMG has provided guidance and educational content
in a clinical trial to capture potential temporal changes
for the Pediatric Sleep Council website; a freely available educational For the Pediatric Sleep
between mediator and outcomes, since improvements in website providing tips to help with sleep in babies and young children. Council website see
paranoia and hallucinations are likely to closely parallel The website is partially supported by Johnson and Johnson, but they do https://www.babysleep.com
not have any influence over content and do not advertise on it.
the improvement in sleep.
AMG contributes to the British Broadcasting Corporation Focus magazine.
This work can be taken forward in several possible
CAE is a co-founder and Chief Medical Officer of the digital cognitive
ways. Determination of the mechanisms linking behavioural therapy for an insomnia programme (Sleepio/Big Health
insomnia to psychotic experiences will shed further light Ltd) and reports other from Big Health Ltd, during the conduct of the
study, and other from Big Health Ltd and personal fees from Warnford
on the causes of psychosis and potentially enable
Wellness, outside the submitted work. CAE has a US patent issued: serial
treatment improvement.3,13 Of great clinical interest will number 14/172,347, Interactive System for Sleep Improvement; docket
be the evaluation of the effects of improving sleep for number HAME-001. All other authors declare no competing interests.
www.thelancet.com/psychiatry Vol 4 October 2017 757
Articles
Acknowledgments 17 Hewitt CE, Torgerson DJ. Is restricted randomisation necessary?
The study was done by the University of Oxford Sleep and Circadian Br Med J 2006; 332: 1506–08.
Neuroscience Institute, with a grant from the Wellcome Trust 18 Luik A, Bostock S, Chisnall L, et al. Treating depression and anxiety
(098461/Z/12/Z). The sleep treatment programme was provided to all with digital cognitive behavioural therapy for insomnia: a real
the trial participants at no cost by Sleepio/Big Health Ltd. RGF and world NHS evaluation using standardized outcome measures.
GMG are the principal investigators for the grant, and DFr and PJH are Behav Cogn Psychother 2017; 45: 91–96.
grant holders. BS is directly funded by the grant. The research in 19 Green CEL, Freeman D, Kuipers E, et al. Measuring ideas of
Nottingham (CHo, EBD, CG) was supported by the National Institute persecution and social reference: the Green et al. Paranoid Thought
Scales (GPTS). Psychol Med 2008; 38: 101–11.
of Health Research (NIHR) MindTech Healthcare Technology
Co-operative. DFr is supported by an NIHR Research Professorship. 20 Ronald A, Sieradzka D, Cardno A, Haworth C, McGuire P,
Freeman D. Characterization of psychotic experiences in adolescence
This study was funded by the Wellcome Trust and supported by the
using the Specific Psychotic Experiences Questionnaire (SPEQ):
NIHR Oxford Health Biomedical Research Centre. The views expressed
findings from a study of 5000 16 year old twins. Schizophr Bull 2014;
are those of the authors and not necessarily those of the National 40: 868–77.
Health Service, NIHR, or Department of Health.
21 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia
References Severity Index as an outcome measure for insomnia research.
1 Harvey AG, Murray G, Chandler R, Soehner A. Sleep disturbance Sleep Med 2001; 2: 297–307.
as transdiagnostic: consideration of neurobiological mechanisms. 22 Krakow BJ, Melendrez DC, Johnston LG, et al. Sleep dynamic
Clin Psychol Rev 2011; 31: 225–35. therapy for Cerro Grande fire evacuees. J Clin Psychiatry 2002;
2 Freeman D, Pugh K, Vorontsova N, Southgate L. Insomnia and 63: 673–84.
paranoia. Schizophr Res 2009; 108: 280–84. 23 Ising HK, Veling W, Loewy RL, et al. The validity of the 16-item
3 Reeve S, Sheaves B, Freeman D. The role of sleep dysfunction in version of the Prodromal Questionnaire (PQ-16) to screen for ultra
the occurrence of delusions and hallucinations. Clin Psychol Rev high risk of developing psychosis in the general help-seeking
2015; 42: 96–115. population. Schizophr Bull 2012; 38: 1288–96.
4 Kendler KS, Campbell J. Interventionist causal models in psychiatry: 24 Kroenke K, Spitzer RL, Williams JBW, Löwe B. The Patient Health
repositioning the mind-body problem. Psychol Med 2009; 39: 881–87. Questionnaire somatic, anxiety, and depressive symptom scales:
5 Dunn G, Emsley R, Liu H, et al. Evaluation and validation of social a systematic review. Gen Hosp Psychiatry 2010; 32: 345–59.
and psychological markers in randomised trials of complex 25 Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for
interventions in mental health: a methodological research assessing generalized anxiety disorder: the GAD-7. Arch Intern Med
programme. Health Technol Assess 2015; 19: 1–115. 2006; 166: 1092–97.
6 Emsley R, Dunn G, White IR. Mediation and moderation of 26 Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman
treatment effects in randomised controlled trials of complex self-rating mania scale. Biol Psychiatry 1997; 42: 948–55.
interventions. Stat Methods Med Res 2010; 19: 237–70. 27 Tennant R, Hiller L, Fishwick R, et al. The Warwick–Edinburgh
7 Taylor M, Gregory A, Freeman D, Ronald A. Do sleep disturbances Mental Well-being Scale (WEMWBS): development and UK
and psychotic experiences in adolescence share genetic and validation. Health Qual Life Outcomes 2007; 5: 63.
environmental influences? J Abnorm Psychol 2015; 124: 674–84. 28 Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social
8 Sheaves B, Porcheret K, Tsanas A, et al. Insomnia, nightmares and Adjustment Scale: a simple measure of impairment in functioning.
chronotype as markers of risk for severe mental illness. Sleep 2016; Br J Psychiatry 2002; 180: 461–64.
39: 173–81. 29 Freeman D, Lister R, Evans N. The use of intuitive and analytic
9 Qaseem A, Kansagara D, Forciea M, Cooke M, Denberg T. reasoning styles by patients with persecutory delusions.
Management of chronic insomnia disorder in adults: a clinical J Behav Ther Exp Psychiatry 2014; 45: 454–58.
practice guideline from the American College of Physicians. 30 Gueorguieva R, Krystal J. Move over ANOVA: progress in analyzing
Ann Intern Med 2016; 165: 125–33. repeated-measures data and its reflection in papers published in the
10 Ritterband L, Thorndike F, Ingersoll K, et al. Effect of a web-based Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310–17.
cognitive behaviour therapy for insomnia intervention with a 1-year 31 Baron R, Kenny DA. The moderator-mediator variable distinction
follow-up: a randomized clinical trial. JAMA Psychiatry 2017; in social psychological research. J Pers Soc Psychol 1986; 5: 1173–82.
74: 68–75. 32 Freeman D, Dunn G, Startup H, et al. Effects of cognitive behaviour
11 Espie C, Kyle S, Williams C, et al. A randomized, placebo-controlled therapy for worry on persecutory delusions in patients with
trial of online cognitive behavioral therapy for chronic insomnia psychosis (WIT): a parallel, single-blind, randomised controlled trial
disorder delivered via an automated media-rich web application. with a mediation analysis. Lancet Psychiatry 2015; 2: 305–13.
Sleep 2012; 35: 769–81. 33 Ye YY, Zhang YF, Chen J, et al. Internet-based cognitive behavioral
12 Christensen H, Batterham P, Gosling J, et al. Effectiveness of an therapy for insomnia (ICBT-i) improves comorbid anxiety and
online insomnia program (SHUTi) for prevention of depressive depression—a meta-analysis of randomized controlled trials.
episodes (the GoodNight Study): a randomised controlled trial. PLoS One 2015; 10: e0142258.
Lancet Psychiatry 2016; 3: 333–41. 34 De Jong Y, Mulder C, Boon A, Deen M, van’t Hof M,
13 Freeman D, Waite F, Startup H, et al. Efficacy of cognitive van der Gaag M. Screening for psychosis risk among adolescents in
behavioural therapy for sleep improvement in patients with Child and Adolescent Mental Health Services: a description of the
persistent delusions and hallucinations (BEST): a prospective, first step with the 16-item version of the Prodromal Questionnaire
assessor-blind, randomised controlled pilot study. Lancet Psychiatry (PQ-16). Early Interv Psychiatry 2016; published online Nov 9.
2015; 2: 975–83. DOI:10.1111/eip.12362.
14 Bilderbeck A, Atkinson L, McMahon H, et al. Psychoeducation and 35 Tsanas A, Saunders K, Bilderbeck A, et al. Daily longitudinal
online mood tracking for patients with bipolar disorder. self-monitoring of mood variability in bipolar disorder and
J Affect Disord 2016; 205: 245–51. borderline personality disorder. J Affect Disord 2016; 205: 225–33.
15 Freeman D, Sheaves B, Goodwin G, et al. Effects of cognitive 36 Zachariae R, Lyby M, Ritterband L, O’Toole M. Efficacy of
behavioural therapy for insomnia on the mental health of internet-delivered cognitive-behavioral therapy for insomnia—
university students. Trials 2015; 16: 236. a systematic review and meta-analysis of randomized controlled
16 Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. trials. Sleep Med Rev 2016; 30: 1–10.
The sleep condition indicator: a clinical screening tool to evaluate 37 van Straten A, Cuijpers P. Self-help therapy for insomnia:
insomnia disorder. BMJ Open 2014; 4: e004183. a meta-analysis. Sleep Med Rev 2009; 13: 61–71.
758 www.thelancet.com/psychiatry Vol 4 October 2017
